The modulation of PPAR1 and PPAR2 mRNA expression by ciglitazone in CD3/CD28-activated nave and memory CD4+ T cells

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Norazmi, Mohd Nor ^a   Mohamed, Rafeezul ^a   Nurul, Asma Abdullah ^a   Yaacob, Nik Soriani ^b  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CIGLITAZONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; TRANSFORMING GROWTH FACTOR BETA; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; LEUKOCYTE ANTIGEN; MICROSPHERE;

ARTICLE; CD4+ T LYMPHOCYTE; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION;

ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MICROSPHERES; PPAR GAMMA; RNA, MESSENGER; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES;

EID: 84861030755     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/849195     Document Type: Article

References (38)

1. Trowbridge I. S., Thomas M. L., CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development Annual Review of Immunology 1994 12 85 116 (Pubitemid 24140410)
2. Sallusto F., Lenig D., Frster R., Lipp M., Lanzavecchia A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 1999 401 6754 708 712
3. Muraro P. A., Pette M., Bielekova B., McFarland H. F., Martin R., Human autoreactive CD4+ T cells from naive CD45RA+ and memory CD45RO+ subsets differ with respect to epitope specificity and functional antigen avidity Journal of Immunology 2000 164 10 5474 5481 (Pubitemid 30305232)
4. Gladstone D. E., Golightly M. G., Brannagan T. H., High dose cyclophosphamide preferentially targets nave T (CD45/CD4/RA+) cells in CIDP and MS patients Journal of Neuroimmunology 2007 190 1-2 121 126 (Pubitemid 47625598)
5. Issemann I., Green S., Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 1990 347 6294 645 650
6. Greene M. E., Blumberg B., McBride O. W., Yi H. F., Kronquist K., Kwan K., Hsieh L., Greene G., Nimer S. D., isolation of the human peroxisome proliferator activated receptor cDNA: expression in hematopoietic cells and chromosomal mapping Gene Expression 1995 4 4-5 281 299
7. Braissant O., Foufelle F., Scotto C., Daua M., Wahli W., Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-,-, and- in the adult rat Endocrinology 1996 137 1 354 366 (Pubitemid 26005011)
8. Sundvold H., Lien S., Identification of a novel peroxisome proliferator-activated receptor (PPAR) promoter in man and transactivation by the nuclear receptor ROR 1 Biochemical and Biophysical Research Communications 2001 287 2 383 390 (Pubitemid 32917609)
9. Forman B. M., Tontonoz P., Chen J., Brun R. P., Spiegelman B. M., Evans R. M., 15-deoxy-12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR Cell 1995 83 5 803 812 (Pubitemid 3006324)
10. Willson T. M., Cobb J. E., Cowan D. J., The structure activity relationship between peroxisome proliferator-activated receptor- agonist, and anti-hyperglycaemic activity of thiazolinediones Journal of Medicinal Chemistry 1996 39 665 668
11. Clark R. B., Bishop-Bailey D., Estrada-Hernandez T., Hla T., Puddington L., Padula S. J., The nuclear receptor PPAR and immunoregulation: PPAR mediates inhibition of helper T cell responses Journal of Immunology 2000 164 3 1364 1371 (Pubitemid 30067250)
12. Yang X. Y., Wang L. H., Chen T., Hodge D. R., Resau J. H., DaSilva L., Farrar W. L., Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor (PPAR ) agonists. PPAR co-association with transcription factor NFAT Journal of Biological Chemistry 2000 275 7 4541 4544 (Pubitemid 30108833)
13. Wang P., Anderson P. O., Chen S., Paulsson K. M., Sjgren H. O., Li S., Inhibition of the transcription factors AP-1 and NF- B in CD4 T cells by peroxisome proliferator-activated receptor ligands International Immunopharmacology 2001 1 4 803 812 (Pubitemid 32206542)
14. Yaacob N. S., Kaderi M. A., Norazmi M. N., The expression of cytokine genes in the peritoneal macrophages and splenic CD4- and CD8-positive lymphocytes of the nonobese diabetic mice Journal of Clinical Immunology 2004 24 2 177 184
15. Germain R. N., The art of the probable: system control in the adaptive immune system Science 2001 293 5528 240 245 (Pubitemid 32694729)
16. Harris S. G., Phipps R. P., Bernard I., Van Straaten H., Van Vriesman P. B., Boneu B., Druet P., Saoudi A., The nuclear receptor PPAR is expressed by mouse T lymphocytes and PPAR agonists induce apoptosis European Journal of Immunology 2001 31 4 1098 1105 (Pubitemid 32331614)
17. Liu K., Li Y., Prabhu V., Young L., Becker K. G., Munson P. J., Weng N. P., Augmentation in expression of activation-induced genes differentiates memory from naive CD4+ T cells and is a molecular mechanism for enhanced cellular response of memory CD4+ T cells Journal of Immunology 2001 166 12 7335 7344 (Pubitemid 32525609)
18. Jiang C., Ting A. T., Seed B., PPAR- agonists inhibit production of monocyte inflammatory cytokines Nature 1998 391 6662 82 86 (Pubitemid 28079219)
19. Ricote M., Li A. C., Willson T. M., Kelly C. J., Glass C. K., The peroxisome proliferator-activated receptor- is a negative regulator of macrophage activation Nature 1998 391 6662 79 82 (Pubitemid 28079218)
20. Klotz L., Dani I., Edenhofer F., Nolden L., Evert B., Paul B., Kolanus W., Klockgether T., Knolle P., Diehl L., Peroxisome proliferator-activated receptor control of dendritic cell function contributes to development of CD4+ T cell anergy Journal of Immunology 2007 178 4 2122 2131 (Pubitemid 46233409)
21. Kuiper H., Brouwer M., De Boer M., Parren P., Van Lier R. A. W., Differences in responsiveness to CD3 stimulation between naive and memory CD4+ T cells cannot be overcome by CD28 costimulation European Journal of Immunology 1994 24 9 1956 1960 (Pubitemid 24276519)
22. Klotz L., Schmidt M., Giese T., Sastre M., Knolle P., Klockgether T., Heneka M. T., Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients Journal of Immunology 2005 175 8 4948 4955 (Pubitemid 41456376)
23. Padilla J., Leung E., Phipps R. P., Human B lymphocytes and B lymphomas express PPAR- and are killed by PPAR- agonists Clinical Immunology 2002 103 1 22 33 (Pubitemid 34478417)
24. Zhang X., Rodriguez-Galn M. C., Subleski J. J., Ortaldo J. R., Hodge D. L., Wang J. M., Shimozato O., Reynolds D. A., Young H. A., Peroxisome proliferator-activated receptor- and its ligands attenuate biologic functions of human natural killer cells Blood 2004 104 10 3276 3284 (Pubitemid 39507146)
25. Soller M., Tautenhahn A., Brne B., Zacharowski K., John S., Link H., Von Knethen A., Peroxisome proliferator-activated receptor contributes to T lymphocyte apoptosis during sepsis Journal of Leukocyte Biology 2006 79 1 235 243 (Pubitemid 43054269)
26. Lagathu C., Bastard J. P., Auclair M., Maachi M., Capeau J., Caron M., Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone Biochemical and Biophysical Research Communications 2003 311 2 372 379 (Pubitemid 37340087)
27. Trifilieff A., Bench A., Hanley M., Bayley D., Campbell E., Whittaker P., PPAR- and- but not- agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF- B-independent effect British Journal of Pharmacology 2003 139 1 163 171 (Pubitemid 36645320)
28. Gossner A. G., Bailey S., Hunter N., Hopkins J., Patterns of cytokine gene expression of nave and memory T lymphocytes in vivo Veterinary Immunology and Immunopathology 2002 87 3-4 261 264 (Pubitemid 34665247)
29. Harris S. G., Smith R. S., Phipps R. P., 15-Deoxy-12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway Journal of Immunology 2002 168 3 1372 1379 (Pubitemid 34094508)
30. Lappas M., Permezel M., Georgiou H. M., Rice G. E., Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor- : effect of 15-deoxy-12,14-PGJ2 and troglitazone Journal of Clinical Endocrinology and Metabolism 2002 87 10 4667 4672 (Pubitemid 35247059)
31. Arnold R., Knig W., Peroxisome-proliferator-activated receptor- agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells Virology 2006 346 2 427 439 (Pubitemid 43357886)
32. Sugiyama H., Nonaka T., Kishimoto T., Komoriya K., Tsuji K., Nakahata T., Peroxisome proliferator-activated receptors are expressed in human cultured mast cells: a possible role of these receptors in negative regulation of mast cell activation European Journal of Immunology 2000 30 12 3363 3370 (Pubitemid 32005206)
33. van Kooten C., Rensink I., Pascual-Salcedo D., Van Oers R., Aarden L. A., Monokine production by human T cells; IL-1 production restricted to memory T cells Journal of Immunology 1991 146 8 2654 2658
34. Killeen N., Stuart S. G., Littman D. R., Development and function of T cells in mice with a disrupted CD2 gene EMBO Journal 1992 11 12 4329 4336
35. Kasahara Y., Miyawaki T., Kato K., Kanegane H., Yachie A., Yokoi T., Taniguchi N., Role of interleukin 6 for differential responsiveness of naive and memory CD4+ T cells in CD2-mediated activation Journal of Experimental Medicine 1990 172 5 1419 1424 (Pubitemid 20366217)
36. Huang T. H. W., Razmovski-Naumovski V., Kota B. P., Lin D. S. H., Roufogalis B. D., The pathophysiological function of peroxisome proliferator-activated receptor- in lung-related diseases Respiratory Research 2005 6 102
37. Kannisto K., Sutinen J., Korsheninnikova E., Fisher R. M., Ehrenborg E., Gertow K., Virkamki A., Nyman T., Vidal H., Hamsten A., Yki-Jrvinen H., Expression of adipogenic transcription factors, peroxisome proliferator- activated receptor co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy AIDS 2003 17 12 1753 1762 (Pubitemid 37000093)
38. Su C. G., Wen X., Bailey S. T., Jiang W., Rangwala S. M., Keilbaugh S. A., Flanigan A., Murthy S., Lazar M. A., Wu G. D., A novel therapy for colitis utilizing PPAR- ligands to inhibit the epithelial inflammatory response Journal of Clinical Investigation 1999 104 4 383 389 (Pubitemid 29534322)